FOLD Q1 2020 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$61M+77.8% YoY

Gross Profit

$54M89.2% margin

Operating Income

-$78M-129.0% margin

Net Income

-$89M-147.0% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+9.5%

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$109M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$738M

Total Liabilities

$336M

Stockholders' Equity

$403M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61M	$34M	+77.8%
Gross Profit	$54M	$30M	+80.0%
Operating Income	-$78M	-$81M	+4.0%
Net Income	-$89M	-$120M	+26.1%

Geographic Segments

Non-US

$43M71%

UNITED STATES

$18M29%